Gunderson Dettmer

Tim Kulis

Deals
1
Latest
Sep 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Tim Kulis was named on, most recent first
Sep 2026 RIGImmune –Leyden LabsAcquisitionLegal adviser to RIGImmune (target)Completed–Biotech+1Leyden Labs acquisition of RIGImmune

Deals where Tim Kulis is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.